Search

Displaying results 4121 - 4130 of 5504 in total

Drug
Rosa centifolia flower oil
go.drugbank.com/drugs/DB14363
Investigational
It is not an approved drug.
Drug
NY-ESO-1 peptide vaccine
go.drugbank.com/drugs/DB17498
Investigational
It contains a peptide derived from the cancer-testis antigen (NY-ESO-1).
Drug
MBP134
go.drugbank.com/drugs/DB18686
Experimental
It is under investigation for the treatment of Sudan ebolavirus (SUDV).
Drug
(3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium
go.drugbank.com/drugs/DB02648
Experimental
It is used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias. [PubChem]
Drug
Basic Fibroblast Growth Factor
go.drugbank.com/drugs/DB14131
Investigational
It was originally named basic fibroblast growth factor based upon its chemical properties and to distinguish it from acidic fibroblast growth factor (Fibroblast Growth Factor 1). … It has a 55 percent amino acid residue identity to Fibroblast Growth Factor 1 and has potent heparin-binding activity.
Drug
PR-15
go.drugbank.com/drugs/DB06037
Investigational
PR-15 is a novel anti-platelet protein with the potential to treat arterial thrombosis occurring during acute coronary syndromes without the bleeding risk associated with existing agents.
Drug
WIN 55212-2
go.drugbank.com/drugs/DB13950
Experimental
It is a potent cannabinoid receptor agonist that has been found to be a potent analgesic in a rat model of neuropathic pain. It activates p42 and p44 MAP kinase via receptor-mediated signaling.
Drug
Rifalazil
go.drugbank.com/drugs/DB04934
Investigational
It is being investigated by ActivBiotics for the treatment of various bacterial infections.
Drug
UC-781
go.drugbank.com/drugs/DB05871
Investigational
It is a topical microbicide targeted against the AIDS virus.
Drug
Senicapoc
go.drugbank.com/drugs/DB06280
Investigational
[A259068] It is being investigated for the treatment of sickle cell disease.